2,6-Lutidine → HCID 19436776, compound
Reaction equation
[CH3:1][C:2]([Si:5]([CH3:14])([CH3:13])[C:6]1[CH:10]=[C:9]([OH:11])[N:8]([CH3:12])[N:7]=1)([CH3:4])[CH3:3].Cl[C:16]1[N:17]=[N:18][CH:19]=[C:20]([O:22][CH3:23])[CH:21]=1.N1C(C)=CC=CC=1C>C1(C)C(C)=CC=CC=1>[CH3:4][C:2]([Si:5]([CH3:14])([CH3:13])[C:6]1[CH:10]=[C:9]([O:11][C:16]2[N:17]=[N:18][CH:19]=[C:20]([O:22][CH3:23])[CH:21]=2)[N:8]([CH3:12])[N:7]=1)([CH3:1])[CH3:3]Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
3-[(1,1-Dimethylethyl)dimethylsilyl]-1-methyl-1H-pyrazol-5-ol (0.48 g, 0.0023 mole), 3-chloro-5-methoxypyridazine (0.36 g, 0.00249 mole) and 2,6-lutidine (0.396 mL, 0.003396 moles) were refluxed under N2 in xylene (20 mL) for 18 hours. The mixture was then filtered through silica gel with ethyl acetate and evaporated in vacuo. The crude compound was purified by reverse phase chromatography to give 3-[[3-[(1,1-dimethylethyl)dimethylsilyl]-1-methyl-1H-pyrazol-5-yl]oxy]-5-methoxypyridazine (0.19 g, 26% yield) as a brown solid.
Workup
- filtrationThe mixture was then filtered through silica gel with ethyl acetate
- customevaporated in vacuo
- customThe crude compound was purified by reverse phase chromatography
Sources & evidence
- ORD record
- ord-e4d9a82158314073beef3ce048b37d79
- Source dataset
- uspto-grants-1996_07
- Patent number
- US05536701
Reaction notes
Loading…